1126108

Samer Kazziha MD — FEI 3016577640

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 31, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Sterling Heights, MI (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance